| 1. | Ergot a fungal disease of many cereals
麦角菌：是许多谷类农作物感染的一种真菌病。
|
| 2. | These findings should be considered in evaluating the risk ? benefit ratio of treatment with ergot derivatives
在评估使用麦角?生物进行治疗的风险-效益比率时应考虑到这一点。
|
| 3. | The mean mitral tenting area was significantly greater in ergot - treated patients and showed a linear relationship with the severity of mitral regurgitation
服用麦角?生物的患者其二尖瓣幕状区的均值显著增加，且和二尖瓣返流的严重程度成线性关系。
|
| 4. | Patients treated with ergot derivatives who had grade 3 to 4 regurgitation of any valve had received a significantly higher mean cumulative dose of pergolide or cabergoline than had patients with lower grades
在服用麦角?生物进行治疗的患者中，发生任何瓣膜3到4级返流的患者服用培高利特或卡麦角林的平均累积剂量显著高于瓣膜返流级别较低的患者。
|
| 5. | Conclusions the frequency of clinically important valve regurgitation was significantly increased in patients taking pergolide or cabergoline , but not in patients taking non ? ergot - derived dopamine agonists , as compared with control subjects
结论：与对照组相比，服用培高利特或者卡麦角林的患者临床上发生重要瓣膜返流的频率显著增加，但服用非麦角?生的多巴胺受体激动剂的患者瓣膜返流的发生率却未增加。
|
| 6. | Background case reports and echocardiographic studies suggest that the ergot - derived dopamine agonists pergolide and cabergoline , used in the treatment of parkinson ' s disease and the restless legs syndrome , may increase the risk of cardiac - valve regurgitation
背景：病例报告和超声心动图研究提示，用于治疗帕金森病和不宁腿综合征的药物?麦角?生物，多巴胺受体激动剂培高利特和卡麦角林，可能增加发生心脏瓣膜返流的风险。
|
| 7. | Methods we performed an echocardiographic prevalence study in 155 patients taking dopamine agonists for parkinson ' s disease ( pergolide , 64 patients ; cabergoline , 49 ; and non ? ergot - derived dopamine agonists , 42 ) and 90 control subjects
方法：我们用超声心动图对155例正在服用多巴胺受体激动剂（ 64例服用培高利特， 49例服用卡麦角林， 42例服用非麦角?生的多巴胺受体激动剂）治疗帕金森病的患者和90例对照组进行了一项流行调查。
|
| 8. | Results clinically important regurgitation ( moderate to severe , grade 3 to 4 ) in any valve was found with significantly greater frequency in patients taking pergolide ( 23 . 4 % ) or cabergoline ( 28 . 6 % ) but not in patients taking non ? ergot - derived dopamine agonists ( 0 % ) , as compared with control subjects ( 5 . 6 % )
结果：与对照组相比（ 5 . 6 % ） ，服用培高利特（ 23 . 4 % ）或者卡麦角林的患者（ 28 . 6 % ） ，临床上发生重要的任何瓣膜的返流（中到重度， 3级到4级）的频率显著升高，而服用非麦角?生的多巴胺受体激动剂的患者（ 0 % ）瓣膜返流的发生率却未增加。
|
您当前位置：